Delving into the Latest Updates on Trin Therapeutics GmbH with Synapse

概览

关联

1

项与 Trin Therapeutics GmbH 相关的临床试验

NCT01259518

/ Unknown status临床1期

A Phase I Dose Escalation Study on the Tolerability and Activity of TriN 2755 in Patients With Advanced Solid Tumors and Sarcomas Using Two Different Dosage Regimens

This is an open-label, parallel-group, two-center, safety, activity and pharmacokinetic study of TriN 2755 given at increasing dose levels as intravenous infusions administered over 4 hours. The study is divided into two parts: Part I a dose escalation phase and Part II an extension phase.

开始日期2009-11-01

申办/合作机构

Trin Therapeutics GmbH

[+2]

100 项与 Trin Therapeutics GmbH 相关的临床结果

登录后查看更多信息

0 项与 Trin Therapeutics GmbH 相关的专利（医药）

登录后查看更多信息

100 项与 Trin Therapeutics GmbH 相关的药物交易

登录后查看更多信息

100 项与 Trin Therapeutics GmbH 相关的转化医学

登录后查看更多信息